Drug and Therapeutics Bulletin 2002;40:15-16; doi:10.1136/dtb.2002.40215
Copyright © 2002 by the BMJ Publishing Group Ltd.
Quinupristin + dalfopristin for infections
Relevant BNF section: 5.1.7
▼Quinupristin + dalfopristin* (Synercid-Aventis Pharma Ltd) is a new combination antibacterial product licensed for treating patients with a variety of Gram-positive infections. Here we assess its place in clinical practice.
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
